✦ LIBER ✦

Navigating Breast Cancer: Axon Guidance Molecules as Breast Cancer Tumor Suppressors and Oncogenes

✍ Scribed by Gwyndolen C. Harburg; Lindsay Hinck

Publisher: Springer US
Year: 2011
Tongue: English
Weight: 358 KB
Volume: 16
Category: Article
ISSN: 1083-3021
DOI: 10.1007/s10911-011-9225-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor suppressor genes and breast cancer

✍ Thomas A. Buchholz; Michael M. Weil; Michael D. Story; Eric A. Strom; William A. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

The genetic determinants for most breast cancer cases remain elusive. However, a mutation in a tumor suppressor gene, such as p53, BRCA1, BRCA2, or ATM, has been determined to be one mechanism of breast carcinogenesis. It has been established that inherited mutations in p53, BRCA1, and BRCA2 signifi

Cloning and mutation analysis ofZFP276as

Cloning and mutation analysis ofZFP276as a candidate tumor suppressor in breast cancer

✍ JasmineC.Y. Wong; Nalan Gokgoz; Noa Alon; IreneL. Andrulis; Manuel Buchwald 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 417 KB

Identification of Fat4 as a candidate tu

Identification of Fat4 as a candidate tumor suppressor gene in breast cancers

✍ Chao Qi; Yiwei Tony Zhu; Liping Hu; Yi-Jun Zhu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 382 KB 👁 3 views

## Abstract __Fat__, a candidate tumor suppressor in __Drosophila__, is a component of Hippo signaling pathway involved in controlling organ size. We found that a ∼3 Mbp deletion in mouse chromosome 3 caused tumorigenesis of a non‐tumorigenic mammary epithelial cell line. The expression of __Fat4__

SOCS3 as a tumor suppressor in breast ca

SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL

✍ Johanna L. Barclay; Stephen T. Anderson; Michael J. Waters; Jon D. Curlewis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 589 KB

## Abstract Suppressor of cytokine signaling 3 (SOCS3), as a key regulator of cytokine signaling, has the potential to modulate numerous cellular processes. Its involvement in inflammatory disease is well established, and there is increasing evidence for a role in breast cancer as a regulator of si

Carcinoembryonic antigen and interferon

Carcinoembryonic antigen and interferon as tumor markers in breast cancer

✍ Yoav Horn; Dalia Hacohen; Jacob L. Zeidman; Natalio Walach; Sally Sharf; Adi Hel 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

A total of 239 determinations of CEA plasma levels were performed for 83 breast cancer patients during chemotherapy or follow-up. In addition, 137 plasma samples were assayed for interferon levels. Patient clinical status was carefully scored according to objective criteria and recorded at each eval

Chapter III. 1. Mutations in human breas

Chapter III. 1. Mutations in human breast cancer cells: Dominantly-acting oncogenes and tumor suppressor genes suggest strategies for targeted interference

✍ Bernd Groner; Nancy E. Hynes 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 745 KB

The etiology of breast cancer has been linked in the past to a number of "macroscopic" events which include the family history of cancer, benign breast disease, reproductive history, exposure to estrogens and diet. The disease itself has been analyzed at different stages and premalignant initiation